Semax is a synthetic nootropic peptide used primarily for cognitive enhancement, focus, memory, and neuroprotection. It increases BDNF (brain-derived neurotrophic factor) and protects neurons from hypoxic damage while improving memory and attention. developed by russian researchers specifically for stroke recovery and cognitive enhancement.
If you're looking for something that sharpens mental performance without the jitteriness, crashes, or dependency that comes with stimulants, this is one of the most well-researched options available. It's been a prescription medication in Russia since the early 1990s, used clinically for stroke recovery, traumatic brain injury, cognitive decline, and optic nerve disorders. It's on Russia's List of Vital & Essential Drugs. Outside of that clinical context, it's gained a large following in the nootropic community for its effects on focus, learning, mood, and mental stamina.
Semax is a seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) segment. The critical distinction is that unlike ACTH itself, Semax does not stimulate cortisol release or trigger any hormonal activity. The researchers who developed it at the Russian Academy of Sciences stripped the hormonal effects and kept the neurotrophic ones, then added a Pro-Gly-Pro extension to the C-terminus to make it resistant to enzymatic breakdown and extend its duration of action from minutes to 20-24 hours.
The primary mechanism is upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the hippocampus and frontal cortex. BDNF is essentially fertilizer for your neurons, it supports the growth, survival, and plasticity of brain cells. One study found Semax increases BDNF levels by approximately 1.4x and doubles the expression of TrkB receptors (the receptors through which BDNF exerts its effects). This translates to improved synaptic plasticity, better memory consolidation, and enhanced learning capacity. Semax also activates serotonergic and dopaminergic brain systems, which is where the mood, motivation, and focus effects come from. A rodent study confirmed it activates both systems without the tolerance or crash pattern you see with traditional stimulants. It also inhibits enkephalinase enzymes, which slows the breakdown of your body's natural pain-modulating and mood-regulating peptides.
There's also evidence Semax interacts with the melanocortin receptor system, specifically acting as an antagonist or partial agonist at MC4 and MC5 receptors. This is still being studied, but melanocortin signalling plays a role in appetite regulation, stress response, inflammation, and sexual function, so it's a potentially meaningful secondary pathway.
Cognitive enhancement: In a study of healthy individuals tested after an 8-hour work shift, a single intranasal dose of Semax produced 71% accuracy on a memory test versus 41% in controls. An fMRI study of 24 healthy subjects found that 1% Semax solution increased activity in the default mode network, the brain region associated with memory, self-referential thought, and information processing. Russian clinical data also shows improved attention and short-term memory in both healthy subjects and patients with cognitive impairment.
Neuroprotection and stroke recovery: This is where the most clinical data exists. In a study of 110 stroke patients, two 10-day courses of Semax at 6,000 mcg/day (with a 20-day break between courses) increased plasma BDNF levels and improved rehabilitation timelines. Animal models of ischemic stroke consistently show Semax reduces infarct size, improves neurological function, and enhances post-injury cognitive performance. The peptide's immunomodulatory effects also appear to play a significant role here, a genome-wide transcriptional analysis found Semax significantly influenced immune cell gene expression and promoted new blood vessel formation during early ischemia stages.
Mood and stress resilience: Semax has demonstrated antidepressant-like and anxiolytic-like effects in animal models, consistent with its activation of serotonergic and dopaminergic systems. It attenuates behavioral effects of chronic stress exposure. For most users without pre-existing anxiety disorders, this translates to improved emotional resilience, steadier mood, and better stress tolerance. However, a 1996 study noted an anxiogenic component in Semax's behavioral effects, meaning it can worsen anxiety in people who already have elevated baseline anxiety. If you run anxious, this peptide may not be ideal for you, or you may want to pair it with something like Selank (its anxiolytic counterpart developed by the same Russian research group).
Immune modulation: Semax enhances the expression of chemokines and immunoglobulins and increases immune cell mobility. This isn't its primary use case, but it's a meaningful secondary benefit, particularly during recovery from illness or injury.
Variants: Semax comes in several forms. Standard Semax is the original with the most clinical data behind it. N-Acetyl Semax adds acetylation at the N-terminus, which protects it from degradation by leucine aminopeptidase, making it last roughly 30 minutes longer in blood plasma and potentially offering more sustained effects. N-Acetyl Semax Amidate adds both acetylation and amidation (protection at both ends), making it the most stable and longest-lasting variant with a reported duration of 6-12 hours versus 2-4 hours for standard Semax. The trade-off is that the acetylated variants have less direct clinical research, most of the Russian clinical data is on standard Semax. If you're going with an acetylated form, dose about 30-40% lower than standard Semax due to improved bioavailability.
Women: There's no evidence that Semax works differently in women versus men in terms of its core cognitive and neuroprotective mechanisms. BDNF upregulation, dopamine and serotonin modulation, and neuroprotection aren't sex-dependent pathways. The same doses and protocols apply. The main sex-specific caution is pregnancy and breastfeeding, where there simply isn't enough safety data, so it should be avoided. Women on hormonal contraception don't need to adjust dosing. One area worth noting is that Semax's modulation of the stress response (via its ACTH-derived structure and melanocortin receptor activity) could theoretically interact with HPA axis dynamics, which do differ between sexes, but there's no clinical evidence of this causing issues in women.